Evidence explainerVitamin E (natural d-alpha vs synthetic dl-alpha tocopherol)
400 IU of Vitamin E Is Either 268 mg or 180 mg. The "d" or "dl" on the Label Decides
Vitamin E labels switched from IU to mg, and the conversion depends on whether the vitamin is natural or synthetic. Here is the math, and what the difference does and does not mean.
Key takeaways
- One IU of natural vitamin E equals 0.67 mg of alpha-tocopherol; one IU of synthetic equals 0.45 mg [1].
- So 400 IU is about 268 mg if natural (d-alpha-tocopherol) and 180 mg if synthetic (dl-alpha-tocopherol) [1].
- Synthetic vitamin E is half as active per mg, because the body keeps only four of its eight forms [1].
- The adult RDA is 15 mg/day; most vitamin E-only supplements provide 67 mg (100 IU natural) or more [1].
- The upper limit is 1,000 mg/day, which is 1,500 IU natural or 1,100 IU synthetic [1].
Safety at a glance
From our Vitamin E (natural d-alpha vs synthetic dl-alpha tocopherol) monograph. Published interactions and cautions only, each with its source.
Interactions
- Anticoagulants and antiplatelet drugs. Vitamin E can inhibit platelet aggregation and antagonize vitamin K-dependent clotting factors, raising bleeding risk at large doses, especially with low vitamin K intake. Clinically significant amounts are unknown but probably exceed 400 IU/day.[1]
- Simvastatin plus niacin. An antioxidant combination containing vitamin E, vitamin C, selenium and beta-carotene blunted the rise in HDL cholesterol in people on simvastatin plus niacin.[1]
- Chemotherapy and radiotherapy. Oncologists generally advise against antioxidant supplements during these treatments because they might reduce effectiveness; a systematic review questioned this, and more research is needed.[1]
Who should be careful
- Bleeding risk. High-dose vitamin E may increase bleeding; two trials found more hemorrhagic stroke with alpha-tocopherol. People on blood thinners or antiplatelet drugs, or before surgery, should discuss vitamin E with a clinician.[1][4]
- Men and prostate findings. 400 IU/day of synthetic vitamin E raised prostate cancer by 17% in the SELECT trial of healthy men.[5]
- Cancer treatment. Oncologists generally advise against antioxidant supplements during chemotherapy or radiotherapy.[1]
- Before you start. Talk to your pharmacist or clinician before adding this supplement, especially if you take prescription medicines, are pregnant or breastfeeding, or have a chronic health condition.[1]
Full Vitamin E (natural d-alpha vs synthetic dl-alpha tocopherol) safety section
The evidence, graded
Pulled from our monograph evidence tables. Grades follow our evidence-grading policy.
- Grade BImprovedProstate outcome in healthy men (SELECT extended follow-up)Prostate cancer was 17% more common with vitamin E than placebo (HR 1.17; 99% CI 1.004-1.36): 620 vs 529 men, an absolute increase of 1.6 per 1000 person-years.
- Grade CImprovedAll-cause mortality with high-dosage vitamin ETrials of ≥400 IU/d showed 39 more deaths per 10,000 persons (95% CI 3 to 74); low-dosage trials showed no increase. Risk rose with dosages above 150 IU/d.
Reading the label: d vs dl
Natural vitamin E is RRR-alpha-tocopherol, usually labeled d-alpha-tocopherol. Synthetic vitamin E is all rac-alpha-tocopherol, usually labeled dl-alpha-tocopherol [1].
Many supplements use an ester such as alpha-tocopheryl acetate or succinate to extend shelf life. The body splits and absorbs these esters as efficiently as plain alpha-tocopherol, so "acetate" on the label is not a red flag [1].
The IU to mg conversion
Supplement Facts panels now list vitamin E in mg; FDA required the new labels from January 2020, with smaller companies allowed until January 2021, so older bottles may still show IU [1]. The conversions ODS gives:
Is natural better than synthetic?
Per mg, yes. Synthetic alpha-tocopherol contains equal amounts of eight stereoisomers, and blood and tissues keep only four of them, so a given weight of synthetic vitamin E is half as active as the same weight of natural [1].
What "natural" does not buy you is a better outcome in trials. Large heart trials of natural vitamin E at 400 IU or more found no protection against major heart events [1], and the prostate cancer signal in SELECT came from synthetic vitamin E [2]; we cover the trials in vitamin E and the heart.
How much is too much?
Adults need 15 mg/day of alpha-tocopherol, 19 mg while breastfeeding [1]. Most vitamin E-only supplements provide 67 mg or more, well above that [1].
The upper limit for adults is 1,000 mg/day of supplemental alpha-tocopherol, set because of bleeding effects [1]. Lower amounts are not risk-free: a meta-analysis of 19 trials found more deaths in trials using 400 IU/day or more (39 more per 10,000 people), with risk rising above 150 IU/day [3]. ODS notes vitamin E can raise bleeding risk with warfarin and similar drugs, probably above 400 IU/day [1].
Mixed tocopherols and tocotrienols are sold too, but intake targets count alpha-tocopherol only, and the trials graded on the vitamin E monograph did not test them [1].
Quick answers
How many mg is 1,000 IU of vitamin E?
About 670 mg for natural and 450 mg for synthetic, using ODS factors of 0.67 and 0.45 mg per IU [1]. The adult upper limit is 1,000 mg/day, or 1,500 IU natural and 1,100 IU synthetic [1].
Keep reading
Full monographs
Related articles
- Vitamin E for Your Heart? Three Big Trials Found No Benefit, and Some Found Harm
- B12 After 50 and on Metformin: Why Levels Drop, and What the Trials Say About Fixing Them
- Berberine Side Effects and Drug Interactions: The Liver-Enzyme Problem Nobody Mentions
- Berberine, “Nature’s Ozempic”: What the Trials Actually Show (Hint: About 2 Pounds)
Browse the full Supplement & Nutrient Encyclopedia or all supplement articles.
References
- [1]Vitamin E: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements, 2021.
- [2]Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 2011.
- [3]Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med, 2005.
